Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI vs. heart attacks: could a computer triage chest pain faster?

NCT ID NCT07027891

Diagnosis Sponsor: CHA University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study tests whether an AI tool that reads ECGs can safely and effectively help emergency doctors decide if a patient with chest pain is having a heart attack. About 4,670 adults with chest pain suspicious for a heart attack will be randomly assigned to either AI-assisted or standard care. The main goal is to see if the AI approach misses any serious heart problems within 30 days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 4,670 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * chest pain * suspicious of acute myocardial infarction Exclusion Criteria: * STEMI * Revisit of same symptoms within 1 week * traumatic chest pain * Pneumothorax * Transferred from other hospital diagnosed of AMI * Cardiac arrest * Chest pain of clearly non-cardiac etiology * declined to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chest pain rule out myocardial infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute coronary syndrome acute myocardial infarction Chest Pain Emergencies myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chest pain rule out myocardial infarction Myocardial infarction (MI)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Asan Medical Center

    RECRUITING

    Seoul, 06628, South Korea

  • CHA Bundang Medical Center

    RECRUITING

    Seoul, 06628, South Korea

  • Ewha Womans University

    RECRUITING

    Seoul, 06628, South Korea

  • Gangnam Severance Hospital

    RECRUITING

    Seoul, 06628, South Korea

  • Hanyang University

    RECRUITING

    Seoul, 06628, South Korea

  • Jeonbuk National University Hospital

    RECRUITING

    Seoul, 06628, South Korea

  • Korea University Ansan Hospital

    RECRUITING

    Seoul, 06628, South Korea

  • Korea University Guro Hospital

    RECRUITING

    Seoul, 06628, South Korea

  • Kyung Hee University Hospital

    RECRUITING

    Seoul, 06628, South Korea

  • Samsung Medical Center

    RECRUITING

    Seoul, 06628, South Korea

  • Soonchunhyang University Bucheon Hospital

    RECRUITING

    Seoul, 06628, South Korea

  • Yonsei University Wonju College of Medicine

    RECRUITING

    Seoul, 06628, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.